Latest News

OTC Supplement Linked to Hyperpigmentation


 

Dark Gray-Blue Skin

In the more recent case report, Ms. Patel and Dr. Phelan described a 30-year-old White male patient who presented with dark gray-blue skin coloring on his cheeks, back of his neck, and the backs of his hands and forearms. He had no other medical conditions and did not take any medications or supplements that cause hyperpigmentation while using kratom.

The patient had been taking kratom for years in the wake of an opioid addiction following medications for a high school injury. He developed an opioid use disorder and tried to replace his pain medications with kratom.

“The patient stopped using kratom in May 2022, but the discoloration remains. It has not regressed in the following 16 months after discontinuing kratom use,” the authors wrote, noting that “whether or not the hyperpigmentation is able to regress is unknown.”

Dr. Woolery-Lloyd is a consultant for AbbVie, Incyte, Johnson & Johnson Consumer, LivDerm, and L’Oreal; a speaker for Eli Lilly, Incyte, L’Oreal, and Ortho Dermatologics; and a researcher/investigator for AbbVie, Allergan, Eirion Therapeutics, Galderma, Pfizer, Sanofi, and Vyne Therapeutics.

According to an information page on kratom on the Food and Drug Administration website, health care professionals and consumers can report adverse reactions associated with kratom to the FDA’s MedWatch program.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Parent concerns a factor when treating eczema in children with darker skin types
MDedge Family Medicine
Dietary supplements may play a role in managing vitiligo
MDedge Family Medicine
GVHD raises vitiligo risk in transplant recipients
MDedge Family Medicine
US Dermatologic Drug Approvals Rose Between 2012 and 2022
MDedge Family Medicine
A 74-year-old White male presented with a 1-year history of depigmented patches on the hands, arms, and face, as well as white eyelashes and eyebrows
MDedge Family Medicine
Lichen Sclerosus: The Silent Genital Health Concern Often Missed
MDedge Family Medicine
Treating Pediatric Vitiligo: Consensus Statement Provides Recommendations
MDedge Family Medicine
JAK Inhibitors for Vitiligo: Response Continues Over Time
MDedge Family Medicine
Analysis Finds Low Malignancy Rate in Pediatric Longitudinal Melanonychia
MDedge Family Medicine
Port-Wine Birthmarks: Shorter Interval Laser Treatments Show Promise in Infants
MDedge Family Medicine